FDA Drug Application (076521) for CARBIDOPA AND LEVODOPA by IMPAX LABS

Back to FDA Applications sponsored by IMPAX LABS

Application Number076521
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage25MG;100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCARBIDOPA AND LEVODOPA
Active IngredientCARBIDOPA; LEVODOPA



Back to FDA Applications sponsored by IMPAX LABS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.